Compare Allstate Corp (ALL) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allstate Corp vs Moderna, Inc. — how do they compare? Allstate Corp trades at $262 (market cap $66.31B), while Moderna, Inc. trades at $60.83 (market cap $24.18B). The key difference: Allstate Corp is far larger — about 2.7× Moderna, Inc.'s market cap, and Allstate Corp pays a 1.65% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| ALL | MRNA | |
|---|---|---|
Market Cap | $66.31B | $24.18B |
Sector | Financials | Health |
52-Week High | $275.11 | $81.80 |
52-Week Low | $190.00 | $22.36 |
Enterprise Value | $74.96B | $20.33B |
Dividend Yield | 1.65% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Allstate Corp
On the basis of premium sales, Allstate is one of the largest U.S. property and casualty insurers. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 agencies.
Read more on ALL →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
